As of 2024-12-14, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 3.05 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.90 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is 0.1%.
The range of the Relative Valuation is 3.05 - 3.05 CAD.
| Range | Selected | |
| Trailing P/E multiples | 32.8x - 32.8x | 32.8x |
| Forward P/E multiples | 100.4x - 100.4x | 100.4x |
| Fair Price | 3.05 - 3.05 | 3.05 |
| Upside | 0.0% - 0.1% | 0.1% |
| Date | P/E |